The DOI matches its Crossref record; 313 of the 313 references it cites were found in a registry or an index.
Citalopram versus other anti-depressive agents for depression
Open accessAbstract
BACKGROUND: Recent US and UK clinical practice guidelines recommend that second-generation antidepressants should be considered amongst the best first-line options when drug therapy is indicated for a depressive episode. Systematic reviews have already highlighted some differences in efficacy between second-generation antidepressants. Citalopram, one of the first selective serotonin reuptake inhibitors (SSRI) introduced in the market, is one of these antidepressant drugs that clinicians use for routine depression care. OBJECTIVES: To assess the evidence for the efficacy, acceptability and tolerability of citalopram in comparison with tricyclics, heterocyclics, other SSRIs and other conventional and non-conventional antidepressants in the acute-phase treatment of major depression. SEARCH METHODS: We searched The Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Register and the Cochrane Central Register of Controlled Trials up to February 2012. No language restriction was applied. We contacted pharmaceutical companies and experts in this field for supplemental data. SELECTION CRITERIA: Randomised controlled trials allocating patients with major depression to citalopram versus any other antidepressants. DATA COLLECTION AND ANALYSIS: Two reviewers independently extracted data. Information extracted included study characteristics, participant characteristics, intervention details and outcome measures in terms of efficacy (the number of patients who responded or remitted), patient acceptability (the number of patients who failed to complete the study) and tolerability (side-effects). MAIN RESULTS: Thirty-seven trials compared citalopram with other antidepressants (such as tricyclics, heterocyclics, SSRIs and other antidepressants, either conventional ones, such as mirtazapine, venlafaxine and reboxetine, or non-conventional, like hypericum). Citalopram was shown to be significantly less effective than escitalopram in achieving acute response (odds ratio (OR) 1.47, 95% confidence interval (CI) 1.08 to 2.02), but more effective than paroxetine (OR 0.65, 95% CI 0.44 to 0.96) and reboxetine (OR 0.63, 95% CI 0.43 to 0.91). Significantly fewer patients allocated to citalopram withdrew from trials due to adverse events compared with patients allocated to tricyclics (OR 0.54, 95% CI 0.38 to 0.78) and fewer patients allocated to citalopram reported at least one side effect than reboxetine or venlafaxine (OR 0.64, 95% CI 0.42 to 0.97 and OR 0.46, 95% CI 0.24 to 0.88, respectively). AUTHORS' CONCLUSIONS: Some statistically significant differences between citalopram and other antidepressants for the acute phase treatment of major depression were found in terms of efficacy, tolerability and acceptability. Citalopram was more efficacious than paroxetine and reboxetine and more acceptable than tricyclics, reboxetine and venlafaxine, however, it seemed to be less efficacious than escitalopram. As with most systematic reviews in psychopharmacology, the potential for overestimation of treatment effect due to sponsorship bias and publication bias should be borne in mind when interpreting review findings. Economic analyses were not reported in the included studies, however, cost effectiveness information is needed in the field of antidepressant trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–313 of 313
Efficacy and Tolerability of Reboxetine Compared with Citalopram
Langworth, S., Bodlund, O., & Ågren, H. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000204138.20417.c3 · Cited by 45
Remission of maternal depression and child symptoms among single mothers: A STAR*D-Child report
Talati, A., WICKRAMARATNE, P. J., Pilowsky, D. J., Alpert, J. E., Cerda, G., Garber, J., Hughes, C. W., King, C. A., Malloy, E., Sood, A. B., et al. (2007) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-007-0262-4 · Cited by 45
Escitalopram in the Long-term Treatment of Major Depressive Disorder
Wade, A. G., Despiégel, N., & Reines, E. H. (2006) · Annals of Clinical Psychiatry · doi:10.1080/10401230600614447 · Cited by 44
Haffmans, P. M. J., Timmerman, L., & Hoogduin, C. A. L. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199609000-00002 · Cited by 44
GÖDER, R., SEECK-HIRSCHNER, M., STINGELE, K., HUCHZERMEIER, C., KROPP, C., PALASCHEWSKI, M., ALDENHOFF, J., & KOCH, J. (2011) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2011.00914.x · Cited by 43
Muhonen, L. H., Lahti, J. M. T., Sinclair, D., Lönnqvist, J. K., & Alho, H. (2008) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-3-20 · Cited by 43
Leinonen, E. V. J., Lepola, U. M., Koponen, H., et al. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09953.x · Cited by 42
Møller, S. E., de Beurs, P., Timmerman, L., Tan, B. K., Leijnse-Ybema, H. J., Stuart, M., & Petersen, H. E. H. (1986) · Psychopharmacology · doi:10.1007/bf00310520 · Cited by 42
A double‐blind comparison of citalopram (Lu 10–171) and amitriptyline in depressed patients
Gravem, A., Amthor, K.-F., Astrup, C., Elgen, K., GJESSING, L. R., Gunby, B., Pettersen, R., Kyrdalen, L., Vaadal, J., Øfsti, E., et al. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02821.x · Cited by 41
A Comparison of the Antidepressant Action of Citalopram and Amitriptyline
Shaw, D., Thomas, D. R., Briscoe, M. H., Crimmins, R., Harris, B., Lovett, J., Raj, M., Lloyd, A. T., Osborne, C., Hughes, G., et al. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.149.4.515 · Cited by 40
Quante, A., Zeugmann, S., Luborzewski, A., Schommer, N. C., Langosch, J. M., Born, C., Anghelescu, I. G., & Wolf, J. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1096 · Cited by 40
Puozzo, C., Lens, S., Reh, C., Michaelis, K., Rosillon, D., Deroubaix, X., & Deprez, D. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544090-00007 · Cited by 39
Bech, P. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90059-6 · Cited by 38
A randomised, double-blind comparison of milnacipran and imipramine in the treatment of depression
Amerongen, A. P. V., Ferrey, G., & Tournoux, A. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00422-0 · Cited by 38
Rapoport, M. J., Mitchell, R. A., McCullagh, S., Herrmann, N., Chan, F., Kiss, A., Feinstein, A., & Lanctôt, K. L. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05086blu · Cited by 38
Schäfer, A., Scheurlen, M., Seufert, J., Keicher, C., Weißbrich, B., Rieger, P., & Kraus, M. R. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.007 · Cited by 36
Subsyndromal Depressive Symptoms in Middle-Aged and Older Persons with Schizophrenia
Zisook, S., Montross, L. P., Kasckow, J., Mohamed, S., Palmer, B. W., Patterson, T. L., Golshan, S., Fellows, I. E., Lehman, D., & Solorzano, E. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3180a725ec · Cited by 36
Gourion, D. (2008) · L Encéphale · doi:10.1016/j.encep.2007.12.001 · Cited by 35
Orthostatic side effects of clomipramine and citalopram during treatment for depression
Christensen, P., Thomsen, H. Y., Pedersen, O. L., Gram, L. F., & Kragh-S�rensen, P. (1985) · Psychopharmacology · doi:10.1007/bf00427895 · Cited by 35
Amsterdam, J. D., Justine Shults, A., Rutherford, N., & Schwartz, S. J. (2006) · Neuropsychobiology · doi:10.1159/000100369 · Cited by 34
Selective serotonin reuptake inhibitors
Geddes, J. R., & Cipriani, A. (2004) · BMJ · doi:10.1136/bmj.329.7470.809 · Cited by 34
Self-citationTreatment of depression in type 2 diabetes with Fluoxetine or Citalopram?
Khazaie, H., Rahimi, M., Tatari, F., Rezaei, M., Najafi, F., & Tahmasian, M. (2011) · Neurosciences · doi:10.17712/1658-3183.1831 · Cited by 34
Thorell, L., Kjellman, B., Arned, M., Lindwall-Sundel, K., Wålinder, J., & Wetterberg, L. (1999) · PubMed · Cited by 33
Dougherty, D. D., Jameson, M., Deckersbach, T., Loh, R., Thompson‐Hollands, J., Jenike, M. A., & Keuthen, N. J. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833119d8 · Cited by 33
Impact of close family members on older adults' early response to depression treatment.
Martire, L. M., Schulz, R., Reynolds, C. F., Morse, J. Q., Butters, M. A., & Hinrichsen, G. A. (2008) · Psychology and Aging · doi:10.1037/0882-7974.23.2.447 · Cited by 33
Efficacy of intravenous citalopram compared with oral citalopram for severe depression
Guelfi, J., Strub, N., & Loft, H. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00120-2 · Cited by 33
Superiority of escitalopram to paroxetine in the treatment of depression
Kasper, S. F., Baldwin, D. S., Lönn, S. L., & Boulenger, J. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.12.003 · Cited by 32
New Possibilities of Treatment for Panic Attacks in Elderly Patients
Rampello, L., Alvano, A., Raffaele, R., Malaguarnera, M., & Vecchio, I. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000195383.96383.25 · Cited by 32
What are evidence-based treatment recommendations?
Barbui, C., & Cipriani, A. (2011) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796011000084 · Cited by 32
Self-citationMinelli, A., Bortolomasi, M., Scassellati, C., Salvoro, B., Avesani, M., & Manganotti, P. (2010) · Brain Stimulation · doi:10.1016/j.brs.2009.04.003 · Cited by 31
Cost-Effectiveness of Escitalopram versus Citalopram in the Treatment of Severe Depression
Hemels, M. E. H., Kasper, S. F., Walter, E., & Einarson, T. R. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e010 · Cited by 31
Martinez, J. M., Katon, W. J., Greist, J. H., Kroenke, K., Thase, M. E., Meyers, A. L., Edwards, S. E., Marangell, L. B., Shoemaker, S., & Swindle, R. W. (2011) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32834ce11b · Cited by 30
Hennig, J., Lange, N., Haag, A., Rohrmann, S., & Netter, P. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700002029 · Cited by 30
A double-blind double-dummy study of citalopram comparing infusion versus oral administration
Baumann, P., Nil, R., Bertschy, G., Jecker, A., Brändli, H., Morand, J., Kasas, A., Vuagniaux, O., & Ramseier, F. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00024-x · Cited by 30
Bougerol, T., Scotto, J., Patris, M., Strub, N., Lemming, O. M., & Petersen, H. E. H. (1997) · Clinical Drug Investigation · doi:10.2165/00044011-199714020-00001 · Cited by 29
Lam, R. W. M., Andersen, H. F., & Wade, A. G. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282ffdedc · Cited by 29
Mannu, P., Rinaldi, S., Fontani, V., Castagna, A., & Margotti, M. L. (2009) · Acupuncture & Electro-Therapeutics Research · doi:10.3727/036012909803861040 · Cited by 29
Ou, J., Xun, G., Wu, R., Li, L., Fang, M., Zhang, H., Xie, S., Shi, J., Du, B., Yuan, X.-Q., et al. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1822-y · Cited by 27
Ford, A. H., Flicker, L. A., McCaul, K. A., van Bockxmeer, F., Hegarty, S., Hirani, V., Fenner, S. G., & Almeida, O. P. (2010) · Trials · doi:10.1186/1745-6215-11-8 · Cited by 27
Frank, M. G., Hendricks, S. E., Burke, W. J., & JOHNSON, D. R. (2004) · Psychological Medicine · doi:10.1017/s0033291703001272 · Cited by 26
Lalit, V., Appaya, P., Hegde, R. P., Mital, A. K., Mittal, S., Nagpal, R., Palaniappun, V., Ramsubramaniam, C., Rao, G. P., Roy, K., et al. (2004) · PubMed Central · Cited by 25
Why it is important to include unpublished data in systematic reviews
Trespidi, C., Barbui, C., & Cipriani, A. (2011) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796011000217 · Cited by 25
Self-citationVenlafaxine for major depression
Cipriani, A., Geddes, J. R., & Barbui, C. (2007) · BMJ · doi:10.1136/bmj.39098.457720.be · Cited by 24
Self-citationThomas, L., Mulligan, J., Mason, V. L., Tallon, D., Wiles, N., Cowen, P. J., Nutt, D., O’Donovan, M. C., Sharp, D., Peters, T., et al. (2008) · Trials · doi:10.1186/1745-6215-9-29 · Cited by 24
Muhonen, L. H., Lönnqvist, J. K., Lahti, J. M. T., & Alho, H. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.05.001 · Cited by 23
Wu, E. Q., Greenberg, P. E., Yang, E., Yu, A., & Erder, M. H. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802303525 · Cited by 23
Hegerl, U., Mergl, R., Henkel, V., Pogarell, O. M., Muller-Siecheneder, F., Frodl, T., & Juckel, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1983-7 · Cited by 23
Gartlehner, G., Chapman, A. L., Strobelberger, M., & Thaler, K. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011895 · Cited by 22
Fuglum, E., Rosenberg, C., Damsbo, N., Stage, K. B., Lauritzen, L., & Bech, P. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb09819.x · Cited by 22
Leonard, B. E., & Taylor, D. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109349835 · Cited by 22
Maas, D. W., Westendorp, R. G. J., Willems, J. M., de Craen, A. J. M., & van der Mast, R. C. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181dcf0de · Cited by 20
Altamura, A. C., Dell’Osso, B. M., Buoli, M., Zanoni, S., & Mundo, E. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31817d5931 · Cited by 20
Citalopram and Viloxazine in the treatment of depression by means of slow drop infusion
Bouchard, J. M., Strub, N., & Nil, R. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00078-5 · Cited by 20
Escitalopram: In the Treatment of Major Depressive Disorder in Adolescent Patients
Yang, L. P. H., & Scott, L. J. (2010) · Pediatric Drugs · doi:10.2165/11204340-000000000-00000 · Cited by 20
Boulenger, J.-P., Hermès, A., Huusom, A. K. T., & Weiller, E. (2010) · Current Medical Research and Opinion · doi:10.1185/03007990903482467 · Cited by 19
A comparative study of milnacipran and imipramine in the treatment of major depressive disorder
López-Ibor, J. J., Conesa, A., & the Spanish Milnacipran/Imipramine Group (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125003719 · Cited by 19
Ahlfors, U. G., Elovaara, S., Harma, P., Suoniemi, I., Heikkilä, L., Nummi, K., Vartiainen, A., Vartiainen, H., Tamminen, T., Elgen, K., et al. (1988) · Nordic Journal of Psychiatry · doi:10.3109/08039488809094957 · Cited by 19
Hosák, L., Tůma, I., Hanuš, H., & Straka, L. (2000) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2019.127 · Cited by 18
Using non-steroidal anti-inflammatory drugs in the treatment of depression.
Davis, A., Gilhooley, M. J., & Agius, M. A. (2010) · PubMed · Cited by 17
Daly, E., Trivedi, M. H., D, M. F. M., Shelton, R. C., Wisniewski, S. R., Morris, D. W., Stegman, D., Preskorn, S., & Rush, A. J. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318205e17b · Cited by 17
Robinson, R. G., Tenev, V., & Jorge, R. E. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181a88423 · Cited by 17
Amsterdam, J. D., Justine Shults, A., & Rutherford, N. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.019 · Cited by 16
Okumura, K., & Furukawa, T. A. (2006) · Clinical Drug Investigation · doi:10.2165/00044011-200626030-00003 · Cited by 16
Self-citationSmith, G. S., Workman, C. I., Kramer, E., Hermann, C. R., Ginsberg, R., Ma, Y., DHAWAN, V. M., Chaly, T., & Eidelberg, D. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181eafde4 · Cited by 16
Milnacipran versus other anti-depressive agents for depression
Nakagawa, A., Watanabe, N., Omori, I. M., Cipriani, A., Barbui, C., McGuire, H., Churchill, R. C., Furukawa, T. A., & Ant, M.-A. O. N. G. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006529 · Cited by 16
Self-citationThase, M. E., Ninan, P. T., Musgnung, J. J., & Trivedi, M. H. (2011) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.10m00979blu · Cited by 15
Lindsley, C. W. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100070s · Cited by 14
Matreja, P. S., Badyal, D. K., Khosla, P. P., & Deswal, R. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.864 · Cited by 13
Sertraline versus other anti-depressive agents for depression
Malvini, L., Cipriani, A., Furukawa, T. A., Nakagawa, A., McGuire, H., Churchill, R. C., Barbui, C., & Ant, M.-A. O. N. G. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006117 · Cited by 13
Self-citationLakey, S. L., Gray, S. L., Ciechanowski, P. S., Schwartz, S. J., & LoGerfo, J. P. (2008) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2008.03.004 · Cited by 12
Citalopram versus other anti-depressive agents for depression
Imperadore, G., Cipriani, A., Signoretti, A., Furukawa, T. A., Watanabe, N., Churchill, R. C., McGuire, H., Barbui, C., & Purgato, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534 · Cited by 12
Self-citationKasckow, J., Fellows, I. E., Golshan, S., Solorzano, E., Meeks, T. W., & Zisook, S. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181dba12f · Cited by 11
Why internal and external validity of experimental studies are relevant for clinical practice?
Cipriani, A., Purgato, M., & Barbui, C. (2009) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00000968 · Cited by 11
Self-citationPharmacokinetic Consequences of a Citalopram Treatment Discontinuation
Voirol, P., Rubin, C., Bryois, C., Kosel, M., Buclin, T., & Baumann, P. (1999) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199906000-00001 · Cited by 11
Escitalopram versus placebo in the treatment of dysthymic disorder
Hellerstein, D. J., Batchelder, S. T., Hyler, S. E., Arnaout, B., Toba, C., Benga, I., & Gangure, D. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328333c35e · Cited by 10
Hsu, J.-W., Su, T., Huang, C.-Y., Chen, Y.-S., & Chou, Y.-H. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822c091a · Cited by 10
Dunbar, G., & Hosford, D. A. (2010) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(10)70458-2 · Cited by 9
Altamura, A. C., Dell’Osso, B. M., Buoli, M., Bosi, M. F., & Mundo, E. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282fe9d54 · Cited by 9
Raisi, F., Habibi, N., Nasehi, A. A., & Akhondzadeh, S. (2007) · Therapy · doi:10.2217/14750708.4.2.187 · Cited by 8
Stein, M. D., Solomon, D. A., Anderson, B. J., Herman, D. S., Anthony, J. L., Brown, R. A., Ramsey, S. E., & Miller, I. W. (2005) · American Journal on Addictions · doi:10.1080/10550490591003684 · Cited by 8
After the failure of citalopram for depression, what next?
Doggrell, S. A. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.11.1515 · Cited by 7
Escitalopram is efficacious and well tolerated in the treatment of depression in primary care
Reines, E. H., Loft, H., & Lepola, U. M. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)80328-5 · Cited by 7
Multifactor analysis on the curative effect of acupuncture in patients with cerebral infarction
Chen, S., & Hong, L. (2005) · Cited by 7
Fluvoxamine versus other anti-depressive agents for depression
Omori, I. M., Watanabe, N., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., Churchill, R. C., Furukawa, T. A., & Ant, M.-A. O. N. G. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006114 · Cited by 7
Self-citationSchmitt, L., Tonnoir, B., & Arbus, C. (2006) · Neuropsychobiology · doi:10.1159/000100368 · Cited by 6
Benkelfat, C., Poirier, M. F., Léouffre, P., Gay, C., & Löo, H. (1987) · The Canadian Journal of Psychiatry · doi:10.1177/070674378703200303 · Cited by 6
Diniz, J. B., Pereira, C. A. D. B., Shavitt, R. G., & Miguel, E. C. (2011) · F1000Research · doi:10.7490/f1000research.1197.1 · Cited by 5
Gałecki, P., Florkowski, A., Pietras, T., Kołodziejska, I., Nowakowski, T., Pawełczyk, A. M., & Zboralski, K. (2004) · PubMed · Cited by 5
Escitalopram versus other anti-depressive agents for depression
Cipriani, A., Pontarollo, F., Signoretti, A., Furukawa, T. A., Nakagawa, A., Churchill, R. C., McGuire, H., Barbui, C., & Ant, M.-A. O. N. G. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006532 · Cited by 5
Self-citationClinical control study of citalopram and amitriptyline in the treatment of post-stroke depression
Guo-ho, H. (2006) · The Journal of Clinical Psychiatry · Cited by 4
Fluoxetine versus other types of pharmacotherapy for depression
Cipriani, A., Brambilla, P., Barbui, C., & Hotopf, M. H. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185 · Cited by 4
Self-citationAydemır, Ö., Ergün, H., Kesebir, S., Soygür, H., & Tulunay, C. F. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20110627111533 · Cited by 3
Olanzapine in the treatment of depression with psychotic features: A prospective open-label study
Adli, M., Wiethoff, K., Baethge, C., Pfennig, A., Stamm, T. J., & Bauer, M. (2008) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500801911144 · Cited by 3
Comparative Study of Citalopram Combined with Amitriptyline for Treat-ment of Refractory Depression
Yang, C., 温全球, 王旭荣, & 陆小兵 (2005) · Guoji yiyao weisheng daobao · doi:10.3760/cma.j.issn.1007-1245.2005.04.037 · Cited by 3
Escitalopram is efficacious and well tolerated for the treatment of depression in primary care
Lepola, V., Loft, H., & Reines, E. H. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)80242-x · Cited by 3
Wise, T. N. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0161-3 · Cited by 2
Leinonen, E. V. J., Skarstein, J., Behnke, K., Ångren, H., & Schutte, A. J. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)80246-1 · Cited by 2
A Comparative study of citalopram and Paroxetine in the treatment of depression
Jian-xi, Y. (2006) · Medical Journal of Chinese People's Health · Cited by 2
Advances in Treatment-Resistant Depression
Shah, A. A. (2024) · Psychiatric Annals · doi:10.3928/00485713-20240617-01 · Cited by 2
Akimova, E., Lanzenberger, R. R., Savli, M., Häusler, D., Wadsak, W., Spindelegger, C., Moser, U., Fink, M., Kletter, K., & Kasper, S. F. (2010) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(10)70552-6 · Cited by 1
Trazodona combinada con ISRS e ISRN en pacientes deprimidos que presentan ansiedad e insomnio
Llácer, J. M. B., Gandía, R., Català, J. M., & Martínez, E. P. (2007) · Psiquiatría Biológica · doi:10.1016/s1134-5934(07)73286-4 · Cited by 1
Cooper‐Kazaz, R., Rigbi, A., & Lerer, B. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.04.007 · Cited by 1
Höflich, A. S., Philippe, C., Savli, M., Baldinger, P., Kranz, G. S., Müller, S., Häusler, D., Zgud, S., Kraus, C., Wadsak, W., et al. (2011) · European Psychiatry · doi:10.1016/s0924-9338(11)72634-7 · Cited by 1
Akimova, E. (2011) · European Psychiatry · doi:10.1016/s0924-9338(11)72305-7 · Cited by 1
Raskin, J., Granger, R. E., Hussain, N., Zhao, G. W., & Marangell, L. B. (2011) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(11)70622-8 · Cited by 1
An open-label, controlled study of citalopram versus moclobemide in patients with major depression
de Alba, L. C., & de, R. M.-M. (1998) · Current Therapeutic Research · doi:10.1016/s0011-393x(98)85005-4 · Cited by 1
THE ASSOCIATION OF DIABETES MELLITUS WITH RESPONSE TO DEPRESSION TREATMENT
Bryan, C. J. (2006) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Controlled study of citalopram and venlafaxine in treatment of patients with senile depression
Zeng-pin, H. (2006) · The Journal of Clinical Psychiatry · Cited by 1
Comparative study of citalopram and maprotiline in treatment of depression
Dong-hon, D. (2005) · Cited by 1
The Effect Observation of Citalopram in the Treatment of Patients with Depression
Chun-liu, Q. (2005) · Journal of Shantou University Medical College · Cited by 1
Efficacy of nimodipine combined with citalopram in treatment of 68 patients with vascular depression
Li, W., & Sha, N. (2006) · Chinese Journal of New Drugs and Clinical Remedies · Cited by 1
Adults with Both Anxiety and Depression Respond Poorly to Treatment
(2008) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)31389-4 · Cited by 1
Cited by
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Sertraline versus other antidepressive agents for depression
Cipriani, A., La Ferla, T., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R., McGuire, H., & Barbui, C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006117.pub4 · Cited by 299
Self-citationNewer generation antidepressants for depressive disorders in children and adolescents
Hetrick, S. E., McKenzie, J. E., Cox, G. R., Simmons, M. B., & Merry, S. N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004851.pub3 · Cited by 291
Turrini, G., Purgato, M., Acarturk, C., Anttila, M., Au, T., Ballette, F., Bird, M., Carswell, K., Churchill, R., Cuijpers, P., et al. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796019000027 · Cited by 258
Self-citationFluoxetine versus other types of pharmacotherapy for depression
Magni, L. R., Purgato, M., Gastaldon, C., Papola, D., Furukawa, T. A., Cipriani, A., & Barbui, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185.pub3 · Cited by 252
Self-citation
Metadata
- Authors
- Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R., Watanabe, N., & Barbui, C.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2012-07-11
- Volume
- 2012
- Issue
- 7
- Pages
- CD006534-CD006534
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2100278846
- Cited by
- 311
- References
- 313
- FWCI
- 10.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.